ClinicalTrials.gg
DrugBiological

Tagraxofusp clinical trials

Also written SL-401 and Elzonris.

studies test it
19
open now
9
in phase 3
0
first study started
2014

How each study uses tagraxofusp is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tagraxofusp studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 2018 · ELZONRIS · BLA 761116 (FDA, Drugs@FDA)
European Union
7 Jan 2021 · Elzonris · EMEA/H/C/005031 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tagraxofusp
14
Tagraxofusp-erzs
7
Diphtheria Toxin(388)-Interleukin-3 Fusion Protein
4
DT(388)-IL3 Fusion Protein
4
DT388IL3 fusion protein
4

Brand

Elzonris
8

Development codes

SL-401
10

Studies by the year they started

19 studies that test it; most in 2025 (5)

Studies that test tagraxofusp, by start year
YearStudies
20141
20151
20162
20171
20202
20211
20224
20241
20255
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
12
Phase 2
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 14

Stemline Therapeutics, Inc. (5) · M.D. Anderson Cancer Center (4) · Karen Ballen, MD (1) · City of Hope Medical Center (1) · Joshua Zeidner (1) · French Innovative Leukemia Organisation (1) · Dana-Farber Cancer Institute (1) · University of Kansas Medical Center (1)

Often tested with

Tested in the same studies.

Venetoclax (5) · Azacitidine (5) · Decitabine (1) · Pacritinib (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test tagraxofusp.

Studies

Open first, then newest update. How each study uses tagraxofusp is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 1 — tagraxofusp is usual care or a partner of the new treatment

Codes

What other systems call tagraxofusp · ClinicalTrials.gg INT000080

  • MeSH (NLM) C000592123tagraxofuspConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 8ZHS5657EHTAGRAXOFUSPConfirmed FDA, NLM, Wikidata
  • RxNorm 2109055One source FDA
  • Wikidata Q60666292tagraxofusp-erzsConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C64769Tagraxofusp-erzsOne source FDA
  • DrugBank DB14731One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.